Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,894 public trials 2,121 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Active, not recruiting

A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors

NCT05614102

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +31 more
Locations
  • Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's Denver, Colorado, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
  • START | San Antonio San Antonio, Texas, United States
  • Antwerp University Hospital | Oncology Department Antwerp, Belgium
View all 21 locations
View Trial Details
Active, not recruiting

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

NCT06147037

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +42 more
Locations
  • Research Site Palo Alto, California, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Omaha, Nebraska, United States
  • Research Site Cleveland, Ohio, United States
View Trial Details
Active, not recruiting

Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer

NCT03528694

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Research Site Auchenflower, Australia
  • Research Site Box Hill, Australia
  • Research Site Brisbane, Australia
  • Research Site Kogarah, Australia
View all 120 locations
View Trial Details
Active, not recruiting

Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer

NCT03085056

Conditions
Anaplastic Thyroid Cancer, Carcinoma, Neoplasms, +3 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, not recruiting

A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors

NCT05537740

Conditions
Advanced Solid Tumors, Breast Diseases, Breast Neoplasms, +30 more
Locations
  • The University of Chicago Medical Center - Hyde Park - Hematology & Oncology Chicago, Illinois, United States
  • UNC Hospitals - UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
  • START | San Antonio San Antonio, Texas, United States
  • South Texas Accelerated Research Therapeutics | START Rocky Mountain Region West Valley City, Utah, United States
View all 26 locations
View Trial Details
Active, not recruiting

Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by Surgery

NCT01468896

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +8 more
Locations
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Active, not recruiting

Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors

NCT05887492

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +16 more
Locations
  • UCLA Hematology/Oncology Santa Monica, California, United States
  • SCRI at HealthOne Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 13 locations
View Trial Details
Active, not recruiting

Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma

NCT05948475

Conditions
Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
Locations
  • UCLA Medical Center Santa Monica, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • The University of Kansas Cancer Center Westwood, Los Angeles, California, United States
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
View all 87 locations
View Trial Details

Related conditions